Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Co-codamol
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-codamol 30mg/500mg tablets
0407010F0AAAHAH
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 459,960 |
|
Co-codamol 15mg/500mg tablets
0407010F0AAAKAK
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 220,731 |
|
Co-codamol 8mg/500mg tablets
0407010F0AAAAAA
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 189,019 |
|
Co-codamol 30mg/500mg capsules
0407010F0AAADAD
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 164,855 |
|
Co-codamol 30mg/500mg effervescent tablets
0407010F0AAAFAF
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 85,588 |
|
Co-codamol 8mg/500mg effervescent tablets
0407010F0AAACAC
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 38,873 |
|
Co-codamol 15mg/500mg capsules
0407010F0AAAVAV
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 28,039 |
|
Co-codamol 8mg/500mg capsules
0407010F0AAABAB
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 22,063 |
|
Co-codamol 15mg/500mg effervescent tablets sugar free
0407010F0AAAWAW
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 6,186 |
|
Co-codamol 8mg/500mg effervescent tablets sugar free
0407010F0AABABA
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 1,288 |
|
Co-codamol 12.8mg/500mg tablets
0407010F0AAAPAP
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 874 |
|
Co-codamol 30mg/500mg/5ml oral solution sugar free
0407010F0AAAZAZ
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 89 |
|
Co-codamol 30mg/500mg effervescent tablets sugar free
0407010F0AABBBB
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 64 |
|
Co-codamol 30mg/500mg effervescent powder sachets sugar free
0407010F0AAAQAQ
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Co-codamol 60mg/1000mg effervescent pdr sachets sugar free
0407010F0AAARAR
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Co-codamol 60mg/1000mg tablets
0407010F0AAAYAY
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Co-codamol 8mg/500mg/5ml oral liquid
0407010F0AAASAS
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.